{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:53:36Z","timestamp":1782842016034,"version":"3.54.5"},"reference-count":22,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.3892\/etm.2014.1891","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T08:37:21Z","timestamp":1407487041000},"page":"1123-1126","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis"],"prefix":"10.3892","volume":"8","author":[{"given":"BO","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MINTAO","family":"HU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIHUA","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUNCHUAN","family":"PU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAO","family":"PEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONG","family":"HUA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHANGZHI","family":"YAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"issue":"Suppl 1","key":"key20180108130642_b1-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"key20180108130642_b2-etm-08-04-1123","first-page":"293","article-title":"Response to standard of care antiviral treatment in patients with HCV liver cirrhosis - a systematic review","volume":"20","author":"Bota","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"key":"key20180108130642_b3-etm-08-04-1123","first-page":"65","article-title":"Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?","volume":"58","author":"Michielsen","year":"2012","journal-title":"Minerva Gastroenterol Dietol"},{"key":"key20180108130642_b4-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"American Association for the Study of Liver Diseases: Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"key20180108130642_b5-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1440-1746.2007.04883.x","article-title":"Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection","volume":"22","author":"McCaughan","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108130642_b6-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2893.2011.01569.x","article-title":"The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin","volume":"19","author":"Guedj","year":"2012","journal-title":"J Viral Hepat"},{"key":"key20180108130642_b7-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180108130642_b8-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/07853890108995951","article-title":"Treatment of viral hepatitis-2001","volume":"33","author":"Gordon","year":"2001","journal-title":"Ann Med"},{"key":"key20180108130642_b9-etm-08-04-1123","first-page":"268","article-title":"The relationship of rat fibrosis and hyaluronic acid and related proteins","volume":"23","author":"Wu","year":"2010","journal-title":"Chinese Journal of Anatomy"},{"key":"key20180108130642_b10-etm-08-04-1123","first-page":"74","article-title":"Treatment of 54 cases of active hepatocirrhosis with lamivudine combined with Fu Zheng Hua Yu capsule","volume":"21","author":"Cui","year":"2012","journal-title":"Journal of China Pharmaceutical"},{"key":"key20180108130642_b11-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/hep.510260416","article-title":"Localization and cellular sources of activins in normal and fibrotic rat liver","volume":"26","author":"De Bleser","year":"1997","journal-title":"Hepatology"},{"key":"key20180108130642_b12-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/hep.23870","article-title":"Anti-tumor necrosis factor \u03b1 treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C","volume":"52","author":"Brennd\u00f6rfer","year":"2010","journal-title":"Hepatology"},{"key":"key20180108130642_b13-etm-08-04-1123","first-page":"47","article-title":"Effects of \u2018Fuzheng Huayu Decoction\u2019 on hepatocellular apoptosis in rats with DMN liver fibrosis","volume":"39","author":"Tan","year":"2005","journal-title":"Shanghai Journal of Traditional Chinese Medicine"},{"key":"key20180108130642_b14-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2011.05.022","article-title":"Hyporesponsiveness to PegIFN\u03b12B plus ribavirin in patients with hepatitis C-related advanced fibrosis","volume":"56","author":"Prati","year":"2012","journal-title":"J Hepatol"},{"key":"key20180108130642_b15-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/lt.22271","article-title":"PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus","volume":"17","author":"Bzowej","year":"2011","journal-title":"Liver Transpl"},{"key":"key20180108130642_b16-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1142\/S0192415X14500621","article-title":"Chinese prescription Kangen-karyu and Salviae Miltiorrhizae radix improve age-related oxidative stress and inflammatory response through the PI3K\/Akt or MAPK pathways","volume":"42","author":"Park","year":"2014","journal-title":"Am J Chin Med"},{"key":"key20180108130642_b17-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09168451.2014.877815","article-title":"Antibacterial and antioxidant activities and chemical compositions of volatile oils extracted from Schisandra chinensis Baill. seeds using simultaneous distillation extraction method, and comparison with Soxhlet and microwave-assisted extraction","volume":"78","author":"Teng","year":"2014","journal-title":"Biosci Biotechnol Biochem"},{"key":"key20180108130642_b18-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/np4010536","article-title":"Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties","volume":"77","author":"Yu","year":"2014","journal-title":"J Nat Prod"},{"key":"key20180108130642_b19-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.fct.2012.11.022","article-title":"Antioxidant and hepatoprotective effects of Schisandra chinensis pollen extract on CCl4-induced acute liver damage in mice","volume":"55","author":"Cheng","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"key20180108130642_b20-etm-08-04-1123","first-page":"131","article-title":"The expression of Fas and FasL in PBMC of multiple sclerosis patients","volume":"22","author":"Li","year":"2002","journal-title":"Shanghai Journal of Immunology"},{"key":"key20180108130642_b21-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3923\/pjbs.2009.804.808","article-title":"Hepatitis C infection and apoptosis in hepatocellular carcinoma","volume":"12","author":"Alkahtani","year":"2009","journal-title":"Pak J Biol Sci"},{"key":"key20180108130642_b22-etm-08-04-1123","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08820130801897352","article-title":"Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C","volume":"37","author":"Zaki Mel","year":"2008","journal-title":"Immunol Invest"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.1891\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:58:34Z","timestamp":1515452314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.1891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,8]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8,8]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.3892\/etm.2014.1891"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.1891","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,8]]}}}